Premier Research Acquires Specialty Women’s Health and Diagnostics
Premier Research has announced that it has acquired Health Decisions, a Durham, N.C.-based contract research organization focused on clinical development in all areas of women’s health and diagnostics.
Health Decisions has a dual focus on women’s health research and diagnostics and is supported by a network of 500 women’s health sites. Since 1989 the company has conducted more than 300 clinical trials, including more than 200 studies in women’s health indications such as reproductive and sexual health, menopause, pain management, osteoporosis, osteoarthritis, and gynecologic oncology. It has also delivered multiple PMAs and 510(k)s for IVD-focused sponsors that include successful submissions in high-risk HPV, colorectal cancer, and pre-term birth, amongst others.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
